CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,577,126
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 88 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-14 | Funicular Fund, LP | Purchase | +17,410 | $2.33 | $41K | 2,171,100 |
| 2022-04-12 | Funicular Fund, LP | Purchase | +69,398 | $2.32 | $161K | 2,153,690 |
| 2022-04-11 | Funicular Fund, LP | Purchase | +4,655 | $2.32 | $11K | 2,084,292 |
| 2022-04-08 | Funicular Fund, LP | Purchase | +30,660 | $2.31 | $71K | 2,079,637 |
| 2022-04-07 | Funicular Fund, LP | Purchase | +27,450 | $2.32 | $64K | 2,048,977 |
| 2022-04-06 | Funicular Fund, LP | Purchase | +26,806 | $2.30 | $62K | 2,021,527 |
| 2022-04-05 | Funicular Fund, LP | Purchase | +49,728 | $2.30 | $114K | 1,994,721 |
| 2022-04-04 | Funicular Fund, LP | Purchase | +122,342 | $2.26 | $276K | 1,944,993 |
| 2022-04-04 | Funicular Fund, LP | Purchase | +122,342 | $2.26 | $276K | 1,944,993 |
Page 2 of 2 · 29 trades